SCHEMBL2607191

SCHEMBL2607191

CC(C)(C)OC(=O)N1CCC(NC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)c2cc3cc(Cl)ncc3[nH]2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP51A1 Q16850 8/20 0.51
PYGL P06737 3/20 0.51
PYGM P11217 1/20 0.51
MAPT P10636 3/20 0.46
MAPK1 P28482 3/20 0.46
NPSR1 Q6W5P4 3/20 0.46
MEN1 O00255 2/20 0.46
POLB P06746 2/20 0.46
KMT2A Q03164 2/20 0.46
GPR55 Q9Y2T6 1/20 0.46
NTSR1 P30989 1/20 0.45
IDO1 P14902 1/20 0.43
RAB9A P51151 1/20 0.42
YAP1 P46937 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
DNMT3A Q9Y6K1 1/20 0.40
UTS2R Q9UKP6 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2107208 0.90 CYP51A1 (0.50) CYP51A1PYGLPYGMMAPTMAPK1
SCHEMBL2107210 0.90 CYP51A1 (0.50) CYP51A1PYGLPYGMMAPTMAPK1
SCHEMBL2106997 0.90 CYP51A1 (0.58) CYP51A1PYGLPYGMMAPTMAPK1
SCHEMBL2107000 0.90 CYP51A1 (0.58) CYP51A1PYGLPYGMMAPTMAPK1
SCHEMBL2608587 0.90 CYP51A1 (0.51) CYP51A1PYGLPYGMMEN1KMT2A
SCHEMBL2606959 0.89 CYP51A1 (0.56) CYP51A1PYGLPYGM
SCHEMBL2107845 0.88 CYP51A1 (0.53) CYP51A1PYGLPYGMMEN1KMT2A
SCHEMBL2107209 0.88 CYP51A1 (0.50) CYP51A1PYGLPYGMMAPTMAPK1
SCHEMBL2606955 0.87 CYP51A1 (0.55) CYP51A1PYGLPYGM
SCHEMBL2606934 0.87 CYP51A1 (0.55) CYP51A1PYGLPYGM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158622-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2012-04-17 US disclosed
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2009-01-22 US disclosed
US-7405210-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase OSI PHARMACEUTICALS, INC. (US) 2008-07-29 US disclosed
US-7405210-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase OSI PHARMACEUTICALS, INC. (US) 2008-07-29 US disclosed
US-20070244090-A9 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE BRADLEY STUART E 2007-10-18 US disclosed
US-20070244090-A9 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE BRADLEY STUART E 2007-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244090-A9 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE PYGL, PYGM, PYGB CYP51A1 598/4885PYGL 1/4885PYGM 2/4885
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PYGL, PYGM, PYGB CYP51A1 598/4885PYGL 1/4885PYGM 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.